Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days).
van Nieuwkoop C, van't Wout JW, Assendelft WJ, Elzevier HW, Leyten EM, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Kuijper EJ, Pander J, Blom JW, Spelt IC, van Dissel JT. van Nieuwkoop C, et al. BMC Infect Dis. 2009 Aug 19;9:131. doi: 10.1186/1471-2334-9-131. BMC Infect Dis. 2009. PMID: 19691829 Free PMC article. Clinical Trial.
Diabetes and the course of febrile urinary tract infection.
van der Starre WE, Borgdorff H, Vollaard AM, Delfos NM, van 't Wout JW, Spelt IC, Blom JW, Leyten EM, Koster T, Ablij HC, van Dissel JT, van Nieuwkoop C. van der Starre WE, et al. Among authors: van t wout jw. Diabetes Care. 2013 Dec;36(12):e193-4. doi: 10.2337/dc13-0903. Diabetes Care. 2013. PMID: 24265368 Free PMC article. No abstract available.
Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.
van Nieuwkoop C, van der Starre WE, Stalenhoef JE, van Aartrijk AM, van der Reijden TJ, Vollaard AM, Delfos NM, van 't Wout JW, Blom JW, Spelt IC, Leyten EM, Koster T, Ablij HC, van der Beek MT, Knol MJ, van Dissel JT. van Nieuwkoop C, et al. Among authors: van t wout jw. BMC Med. 2017 Apr 3;15(1):70. doi: 10.1186/s12916-017-0835-3. BMC Med. 2017. PMID: 28366170 Free PMC article. Clinical Trial.
Hospitalization for community-acquired febrile urinary tract infection: validation and impact assessment of a clinical prediction rule.
Stalenhoef JE, van der Starre WE, Vollaard AM, Steyerberg EW, Delfos NM, Leyten EMS, Koster T, Ablij HC, Van't Wout JW, van Dissel JT, van Nieuwkoop C. Stalenhoef JE, et al. Among authors: van t wout jw. BMC Infect Dis. 2017 Jun 6;17(1):400. doi: 10.1186/s12879-017-2509-3. BMC Infect Dis. 2017. PMID: 28587665 Free PMC article. Clinical Trial.
Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in predicting outcome of febrile urinary tract infection.
van der Starre WE, Zunder SM, Vollaard AM, van Nieuwkoop C, Stalenhoef JE, Delfos NM, Van't Wout JW, Spelt IC, Blom JW, Leyten EM, Koster T, Ablij HC, van Dissel JT. van der Starre WE, et al. Among authors: van t wout jw. Clin Microbiol Infect. 2014 Oct;20(10):1048-54. doi: 10.1111/1469-0691.12645. Clin Microbiol Infect. 2014. PMID: 25039648 Free article.
Plasma secretory leukocyte protease inhibitor in febrile patients.
Duits LA, Tjabringa GS, Aarts NJ, van't Wout JW, Hiemstra PS, Nibbering PH, van Dissel JT. Duits LA, et al. Clin Microbiol Infect. 2003 Jul;9(7):605-13. doi: 10.1046/j.1469-0691.2003.00582.x. Clin Microbiol Infect. 2003. PMID: 12925099 Free article.
116 results